Your browser doesn't support javascript.
loading
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma.
Xu, Jie; Chen, Li-Juan; Yang, Shuang-Shuang; Sun, Yan; Wu, Wen; Liu, Yuan-Fang; Xu, Ji; Zhuang, Yan; Zhang, Wu; Weng, Xiang-Qin; Wu, Jing; Wang, Yan; Wang, Jin; Yan, Hua; Xu, Wen-Bin; Jiang, Hua; Du, Juan; Ding, Xiao-Yi; Li, Biao; Li, Jun-Min; Fu, Wei-Jun; Zhu, Jiang; Zhu, Li; Chen, Zhu; Fan, Xiao-Hu Frank; Hou, Jian; Li, Jian-Yong; Mi, Jian-Qing; Chen, Sai-Juan.
Afiliação
  • Xu J; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Chen LJ; Department of Hematology, Jiangsu Province Hospital, First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.
  • Yang SS; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Sun Y; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Wu W; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Liu YF; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Xu J; Department of Hematology, Jiangsu Province Hospital, First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China.
  • Zhuang Y; Department of Hematology, Changzheng Hospital, The Second Military Medical University, 200003 Shanghai, China.
  • Zhang W; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Weng XQ; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Wu J; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Wang Y; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Wang J; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Yan H; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Xu WB; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Jiang H; Department of Hematology, Changzheng Hospital, The Second Military Medical University, 200003 Shanghai, China.
  • Du J; Department of Hematology, Changzheng Hospital, The Second Military Medical University, 200003 Shanghai, China.
  • Ding XY; Department of Radiology and Nuclear Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Li B; Department of Radiology and Nuclear Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Li JM; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Fu WJ; Department of Hematology, Changzheng Hospital, The Second Military Medical University, 200003 Shanghai, China.
  • Zhu J; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
  • Zhu L; Nanjing Legend Biotech, 210008 Nanjing, China.
  • Chen Z; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China; zchen@stn.sh.cn frank.fan@legendbiotech.com houjian@medmail.com.c
  • Fan XF; Nanjing Legend Biotech, 210008 Nanjing, China zchen@stn.sh.cn frank.fan@legendbiotech.com houjian@medmail.com.cn lijianyonglm@medmail.com.cn jianqingmi@shsmu.edu.cn sjchen@stn.sh.cn.
  • Hou J; Department of Hematology, Changzheng Hospital, The Second Military Medical University, 200003 Shanghai, China; zchen@stn.sh.cn frank.fan@legendbiotech.com houjian@medmail.com.cn lijianyonglm@medmail.com.cn jianqingmi@shsmu.edu.cn sjchen@stn.sh.cn.
  • Li JY; Department of Hematology, Jiangsu Province Hospital, First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China; zchen@stn.sh.cn frank.fan@legendbiotech.com houjian@medmail.com.cn lijianyonglm@medmail.com.cn jianqingmi@shsmu.edu.cn sjchen@stn.sh.cn.
  • Mi JQ; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China; zchen@stn.sh.cn frank.fan@legendbiotech.com houjian@medmail.com.c
  • Chen SJ; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China; zchen@stn.sh.cn frank.fan@legendbiotech.com houjian@medmail.com.c
Proc Natl Acad Sci U S A ; 116(19): 9543-9551, 2019 05 07.
Article em En | MEDLINE | ID: mdl-30988175
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Transplante de Células-Tronco Hematopoéticas / Antígeno de Maturação de Linfócitos B / Receptores de Antígenos Quiméricos / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Transplante de Células-Tronco Hematopoéticas / Antígeno de Maturação de Linfócitos B / Receptores de Antígenos Quiméricos / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article